Assignee
MANLEY PAUL W
CH·5 granted patents·14 pending applications·70 citations·filing 2006–2014
Top patents by PatentIndex Score
19 records- 0194US8163904B2Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-BenzamideMANLEY PAUL W·Filed 2006·Granted Apr 24, 2012·32 cites·4 claims
- 0292US8389537B2Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2012·Granted Mar 5, 2013·17 cites·2 claims
- 0389US8415363B2Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2012·Granted Apr 9, 2013·15 cites·8 claims
- 0480US8093259B24-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]-benzamide for treatment of melanomaMANLEY PAUL W·Filed 2007·Granted Jan 10, 2012·6 cites·4 claims
- 0566US2010152198A1Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemiaMANLEY PAUL W·Filed 2007·Application pending·0 cites
- 0661US2014343087A1Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2014·Application pending·0 cites
- 0760US2014073660A1Pyrimidylaminobenzamide Derivatives for Treatment of NeurofibromatosisMANLEY PAUL W·Filed 2013·Application pending·0 cites
- 0860US2008318988A1Pyrimidylaminobenzamide Derivatives For the Treatment of NeurofibromatosisMANLEY PAUL W·Filed 2006·Application pending·0 cites
- 0955US2008200488A1Combinations Comprising a Protein Kinase Inhibitor Being a Pyrimidylaminobenzamide Compound and a Hsp90 Inhibitor Such as 17-AagMANLEY PAUL W·Filed 2006·Application pending·0 cites
- 1054US8217045B2Organic compoundsMANLEY PAUL W·Filed 2008·Granted Jul 10, 2012·0 cites·9 claims
- 1154US2013197017A1Combinations comprising a protein kinase inhibitor being a pyrimidylaminobenzamide compound and a hsp90 inhibitor such as 17-11gMANLEY PAUL W·Filed 2013·Application pending·0 cites
- 1252US2011281902A1Combinations comprising a protein kinase inhibitor being a pyrimidylaminobenzamide compound and a hsp90 inhibitor such as 17-aagMANLEY PAUL W·Filed 2011·Application pending·0 cites
- 1352US2010234408A1Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosisMANLEY PAUL W·Filed 2010·Application pending·0 cites
- 1450US2013040972A1USE OF c-Src INHIBITORS IN COMBINATION WITH A PYRIMIDYLAMINOBENZAMIDE COMPOUND FOR THE TREATMENT OF LEUKEMIAMANLEY PAUL W·Filed 2012·Application pending·0 cites
- 1547US2009286803A1Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitorMANLEY PAUL W·Filed 2007·Application pending·0 cites
- 1645US2008255171A1Combination of Nilotinib with Farnesyl Transferase InhibitorsMANLEY PAUL W·Filed 2006·Application pending·0 cites
- 1744US2008207658A1Pharmaceutical Combination of Bcr-Abl and Raf InhibitorsMANLEY PAUL W·Filed 2006·Application pending·0 cites
- 1840US2008114001A1Use of Pyrimidylaminobenzamides for the Treatment of Diseases that Respond to Modulation of Tie-2 Kinase ActivityMANLEY PAUL W·Filed 2006·Application pending·0 cites
- 1936US2008207591A1Organic CompoundsMANLEY PAUL W·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MANLEY PAUL W files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →